The Department of Homeland Security has awarded technology provider Parsons Corp. a multiaward COVID-19 testing indefinite delivery, indefinite quantity contract with a shared ceiling value of $2 billion.
Testing will support DHS employees and includes two functional categories: managed testing services, and molecular diagnostic test kits and testing services.
Parsons will provide flexible, innovative testing solutions designed to keep DHS employees safe and reduce the risk of exposure to COVID-19. The offerings will be point-of-care or laboratory-based solutions that support current and future operational concepts for screening capabilities.
Parsons CEO Chuck Harrington said the company looks forward to teaming with DHS on proactive health solutions.
In May 2020, Parsons independently invented DetectWise, an integrated, touchless suite of health monitoring solutions. The system could be included in the company’s offering for the DHS IDIQ, especially given the need to coordinate the collection of samples from identified subjects.